Leproust M. Emily's most recent trade in Twist Bioscience Corp was a trade of 18,880 Common Stock done at an average price of $95 . Disclosure was reported to the exchange on June 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 25 Jun 2026 | 18,880 | 824,039 (2%) | 0% | 95 | 1,793,600 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 87.32 per share. | 22 Jun 2026 | 1,688 | 842,919 (2%) | 0% | 87.3 | 147,400 | Common Stock |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 4,248 | 4,248 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 3,576 | 24,852 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 3,576 | 0 | - | - | Restricted Stock Unit | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.84 per share. | 08 Jun 2026 | 2,265 | 844,607 (2%) | 0% | 69.8 | 158,197 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 28 May 2026 | 16,470 | 863,342 (2%) | 0% | 8.8 | 145,265 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2026 | 16,470 | 75,439 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 67.95 per share. | 28 May 2026 | 7,623 | 853,337 (2%) | 0% | 68.0 | 517,989 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.61 per share. | 28 May 2026 | 6,465 | 846,872 (2%) | 0% | 68.6 | 443,590 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.33 per share. | 28 May 2026 | 1,482 | 861,860 (2%) | 0% | 65.3 | 96,813 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.85 per share. | 28 May 2026 | 900 | 860,960 (2%) | 0% | 66.8 | 60,163 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 25,017 | 91,909 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 26 May 2026 | 25,017 | 871,889 (2%) | 0% | 8.8 | 220,650 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 24,282 | 116,926 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.08 per share. | 26 May 2026 | 24,282 | 846,872 (2%) | 0% | 65.1 | 1,580,246 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 26 May 2026 | 24,282 | 871,154 (2%) | 0% | 8.8 | 214,167 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 26 May 2026 | 23,752 | 848,137 (2%) | 0% | 65.2 | 1,549,561 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.28 per share. | 26 May 2026 | 1,265 | 846,872 (2%) | 0% | 66.3 | 83,846 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.26 per share. | 21 May 2026 | 6,888 | 846,872 (2%) | 0% | 53.3 | 366,834 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.15 per share. | 04 May 2026 | 5,127 | 853,760 (2%) | 0% | 57.1 | 293,002 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2026 | 8,061 | 141,208 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 21 Apr 2026 | 8,061 | 866,948 (2%) | 0% | 8.8 | 71,098 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.27 per share. | 21 Apr 2026 | 7,910 | 859,038 (2%) | 0% | 65.3 | 516,325 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 21 Apr 2026 | 1,610 | 860,497 (2%) | 0% | 8.8 | 14,200 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2026 | 1,610 | 149,269 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 21 Apr 2026 | 1,610 | 858,887 (2%) | 0% | 65.0 | 104,666 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 21 Apr 2026 | 151 | 858,887 (2%) | 0% | 66 | 9,966 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.79 per share. | 20 Mar 2026 | 1,742 | 858,887 (2%) | 0% | 43.8 | 76,276 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.43 per share. | 06 Mar 2026 | 2,423 | 860,629 (2%) | 0% | 46.4 | 112,490 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.58 per share. | 03 Feb 2026 | 5,001 | 869,312 (2%) | 0% | 46.6 | 232,927 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.56 per share. | 22 Dec 2025 | 1,605 | 874,313 (2%) | 0% | 34.6 | 55,462 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.88 per share. | 08 Dec 2025 | 2,255 | 875,918 (2%) | 0% | 32.9 | 74,140 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.50 per share. | 21 Nov 2025 | 2,663 | 878,173 (2%) | 0% | 26.5 | 70,579 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 146,914 | 880,836 (2%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.08 per share. | 03 Nov 2025 | 4,887 | 733,922 (1%) | 0% | 32.1 | 156,772 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 31,379 | 738,809 (1%) | 0% | 31.4 | 986,691 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2025 | 168,976 | 770,188 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 06 Oct 2025 | 31,348 | 601,212 (1%) | 0% | 32.2 | 1,008,998 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.16 per share. | 02 Oct 2025 | 476 | 632,560 (1%) | 0% | 29.2 | 13,881 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.56 per share. | 22 Sep 2025 | 1,704 | 633,036 (1%) | 0% | 27.6 | 46,962 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.76 per share. | 08 Sep 2025 | 2,265 | 634,740 (1%) | 0% | 25.8 | 58,346 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.96 per share. | 21 Aug 2025 | 2,716 | 637,005 (1%) | 0% | 26.0 | 70,518 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.36 per share. | 04 Aug 2025 | 5,585 | 639,721 (1%) | 0% | 28.4 | 158,413 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.19 per share. | 02 Jul 2025 | 476 | 645,306 (1%) | 0% | 36.2 | 17,228 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.76 per share. | 20 Jun 2025 | 1,678 | 645,782 (1%) | 0% | 35.8 | 59,997 | Common Stock |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 21,276 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.75 per share. | 06 Jun 2025 | 2,170 | 647,460 (1%) | 0% | 31.8 | 68,898 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.75 per share. | 21 May 2025 | 2,802 | 649,630 (1%) | 0% | 29.7 | 83,351 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2025 | 3,000 | 652,432 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.65 per share. | 05 May 2025 | 5,042 | 655,432 (1%) | 0% | 37.7 | 189,836 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.73 per share. | 02 Apr 2025 | 492 | 660,474 (1%) | 0% | 38.7 | 19,057 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.68 per share. | 20 Mar 2025 | 1,726 | 660,966 (1%) | 0% | 41.7 | 71,933 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.91 per share. | 06 Mar 2025 | 2,402 | 662,692 (1%) | 0% | 40.9 | 98,273 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 21 Feb 2025 | 2,790 | 665,094 (1%) | 0% | 44.2 | 123,254 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.35 per share. | 03 Feb 2025 | 5,200 | 667,318 (1%) | 0% | 49.4 | 256,630 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.59 per share. | 03 Jan 2025 | 546 | 672,518 (1%) | 0% | 45.6 | 24,893 | Common Stock |
| Twist Bioscience Corp | Leproust M. Emily | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 20 Dec 2024 | 1,654 | 673,064 (1%) | 0% | 44.9 | 74,270 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 06 Dec 2024 | 2,216 | 674,718 (1%) | 0% | 52.7 | 116,792 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 95,350 | 676,934 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 11 Nov 2024 | 7,968 | 581,584 (1%) | 0% | 48.0 | 382,448 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 06 Nov 2024 | 14,334 | 589,552 (1%) | 0% | 44.6 | 639,368 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 06 Nov 2024 | 14,334 | 589,552 (1%) | 0% | 44.6 | 639,368 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 80,855 | 562,773 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 45,954 | 608,727 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 04 Nov 2024 | 4,841 | 603,886 (1%) | 0% | 41.6 | 201,211 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.21 per share. | 02 Oct 2024 | 13,605 | 481,918 (1%) | 0% | 43.2 | 587,886 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.94 per share. | 20 Sep 2024 | 1,730 | 495,523 (1%) | 0% | 46.9 | 81,208 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.16 per share. | 06 Sep 2024 | 2,340 | 497,253 (1%) | 0% | 39.2 | 91,637 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 05 Aug 2024 | 5,139 | 499,593 (1%) | 0% | 39.9 | 205,180 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 02 Jul 2024 | 1,114 | 504,732 (1%) | 0% | 48.0 | 53,474 | Common Stock |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 8,352 | - | 0 | Class A Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.41 per share. | 20 Jun 2024 | 1,732 | 505,846 (1%) | 0% | 49.4 | 85,578 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.33 per share. | 06 Jun 2024 | 2,408 | 507,578 (1%) | 0% | 51.3 | 123,600 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 03 May 2024 | 4,163 | 509,986 (1%) | 0% | 37.1 | 154,589 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 02 Apr 2024 | 1,132 | 514,149 (1%) | 0% | 32.7 | 37,057 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.52 per share. | 20 Mar 2024 | 1,128 | 515,281 (1%) | 0% | 33.5 | 37,806 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 06 Mar 2024 | 1,487 | 516,409 (1%) | 0% | 37.4 | 55,658 | Common Stock |
| Twist Bioscience Corp | M. Leproust Emily | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.59 per share. | 02 Feb 2024 | 4,722 | 516,605 (1%) | 0% | 36.6 | 172,778 | Common Stock |
| Twist Bioscience Corp | M. Leproust Emily | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.86 per share. | 02 Jan 2024 | 1,181 | 521,327 (1%) | 0% | 36.9 | 43,532 | Common Stock |
| Twist Bioscience Corp | Emily Leproust M. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.33 per share. | 19 Dec 2023 | 1,722 | 522,508 (1%) | 0% | 38.3 | 66,004 | Common Stock |
| Twist Bioscience Corp | Leproust Emily M. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.67 per share. | 05 Dec 2023 | 2,329 | 524,230 (1%) | 0% | 24.7 | 57,456 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. | 18 Aug 2023 | 2,787 | 246,785 (0%) | 0% | 19.5 | 54,235 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.09 per share. | 24 Jul 2023 | 898 | 249,572 (0%) | 0% | 25.1 | 22,531 | Common Stock |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.46 per share. | 30 Jun 2023 | 1,122 | 250,470 (0%) | 0% | 20.5 | 22,956 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.31 per share. | 16 Jun 2023 | 1,748 | 251,592 (0%) | 0% | 18.3 | 32,006 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 64,950 | 64,950 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.03 per share. | 19 May 2023 | 2,754 | 253,340 (0%) | 0% | 13.0 | 35,885 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 24,360 | 0 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 04 May 2023 | 24,360 | 256,094 (0%) | 0% | 6.0 | 144,942 | Common Stock |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 83,290 | - | 0 | Class A Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.63 per share. | 24 Apr 2023 | 898 | 231,734 (0%) | 0% | 13.6 | 12,240 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 31 Mar 2023 | 1,121 | 232,632 (0%) | 0% | 15.1 | 16,905 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.51 per share. | 17 Mar 2023 | 1,748 | 233,753 (0%) | 0% | 16.5 | 28,859 | Common Stock |